← Back to Search

Atrial Fibrillation Screening for Cancer Patients (SARIC Trial)

N/A

Recruiting

Led By Zain Asad, MD

Research Sponsored by University of Oklahoma

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Male and female patients age ≥65 with a current diagnosis or history of cancer.

The age is restricted to ≥65 years because prevalence of AF is extremely low. .

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months

Awards & highlights

SARIC Trial Summary

This trial will study if screening for AF in cancer patients can detect the condition earlier and improve treatment outcomes.

Who is the study for?

This trial is for men and women aged 65 or older who have been diagnosed with cancer, including those currently undergoing or with a history of chemotherapy, radiotherapy, or cancer-related surgeries. It's focused on detecting atrial fibrillation (AF), which is more common in the cancer population.Check my eligibility

What is being tested?

The study tests if a quick, 30-second ECG using Kardia Mobile can spot AF better than routine care in older adults with cancer. This randomized controlled trial aims to find out whether early detection leads to improved treatment outcomes.See study design

What are the potential side effects?

Since this trial involves non-invasive screening with an ECG device and standard medical care, side effects are minimal. However, there may be indirect consequences from any subsequent treatments initiated as a result of the screening findings.

SARIC Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 65 or older with a current or past cancer diagnosis.

Select...

I am 65 years old or older.

SARIC Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

The Investigators will compare the incidence of newly diagnosed AF identified by screening versus usual care

Secondary outcome measures

To determine the effect of screening-detected AF on initiation of anticoagulation.

SARIC Trial Design

2Treatment groups

Active Control

Group I: Screen groupActive Control1 Intervention

Patients randomized to screening will undergo a 30-second ECG using the Kardia Mobile device (AliveCor Inc, Cupertino, CA) paired with an iPad (Apple, Cupertino, CA). If the mobile ECG shows possible AF or unclassified, then patients will undergo a 12-lead standard ECG during the same visit, read by a cardiologist, to verify the correct diagnosis.

Group II: Usual CareActive Control1 Intervention

For patients in the usual care arm, medical record review will be done at end of study to assess for the newly diagnosed AF during the study period.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of OklahomaLead Sponsor

455 Previous Clinical Trials

95,443 Total Patients Enrolled

Zain Asad, MDPrincipal InvestigatorOU Health

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the eligibility criteria for participation in this research project?

"Eligible patients, aged 65-90 years old and diagnosed with cancer, are invited to participate in this medical trial. The recruitment goal is 480 individuals."

Answered by AI

Are applications being accepted for participation in this trial at present?

"The listing on clinicaltrials.gov shows that this medical study is presently enlisting patients, with the original post date being November 6th 2023 and a subsequent update taking place two weeks later."

Answered by AI

Are younger individuals aged below 35 admissible for the research trial?

"To qualify for this clinical trial, individuals must be older than 65 years old and younger than 90."

Answered by AI

What is the magnitude of individuals participating in this research endeavor?

"Right, according to the information on clinicaltrials.gov this research trial is still actively recruiting participants. It was originally posted on November 6th 2023 and has since been modified as recently as November 20th 2023. 480 patients are being sought out for admittance at 1 participating health facility."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Screening for Atrial Fibrillation in Patients With Cancer: A Pilot Randomized Controlled Clinical Trial

2023. "Screening for Atrial Fibrillation in Patients With Cancer: A Pilot Randomized Controlled Clinical Trial". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05784766.